| Emcure Pharmaceuticals IPO - Brokerage Reports | ||
|---|---|---|
| Sr. No. | Brokerage House | Recommendation |
| 1 | Anand Rathi | Subscribe for long term |
| 2 | BP Wealth | Subscribe |
| 3 | Canara Bank Securities | Subscribe for long term |
| 4 | Deven Choksey | Subscribe |
| 5 | Geojit | Subscribe |
| 6 | Hensex Securities | Subscribe for long term |
| 7 | SBI Securities | Subscribe for long term |
| 8 | Marwadi Financial | Subscribe |
| 9 | Mastertrust | Subscribe for long term |
| 10 | Mehta Equities | Subscribe for long term |
| 11 | Nirmal Bang | Subscribe |
| 12 | Reliance Securities | Subscribe |
| 13 | Sushil Finance | Subscribe for medium-long term |
| 14 | Stoxbox | Subscribe |
| 15 | Swastika Invesmart | Subscribe for long term |
| 16 | Ventura Securities | Subscribe |
Emcure Pharmaceuticals garnered Rs 583 crore from anchor investors on July 2, a day before its IPO Opening. Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue. The equity shares of the company are expected to list on the BSE and the NSE on July 10.